Clinical Trials
2 trialsNCT01202370 2013-08-14
A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid Malignancies
University of Kentucky
Phase 1 Completed
NCT00389480 2009-08-11
Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies
Arno Therapeutics
Phase 1 Completed